Showing results (851-860 of 1,906) with videos related to

Sort By:
Pageof 191
Current Neuropharmacology|June 16, 2023
Estrogens as a Possible Therapeutic Strategy for the Management of Neuroinflammation and Neuroprotection in COVID-19Cindy Bandala, Noemí Cárdenas-Rodríguez, Samuel Reyes-Long, et al.
Current Neuropharmacology|April 20, 2026
Targeting HMGB1 to Attenuate Myocardial Ischaemia-reperfusion Injury (MIRI)-induced Cognitive DysfunctionLuyuan Yao, Ye Sun, Qinjun Chu, et al.
Current Neuropharmacology|April 20, 2026
Innovative Approaches to Depression Therapy: The Antidepressant Efficacy and Mechanisms of General AnestheticsXiangying Wei, Shan Xu, Zhaoqiong Zhu
Current Neuropharmacology|April 3, 2026
Fulvestrant Enhances Temozolomide Effectiveness Against Glioblastoma: Insights from a Preclinical StudyCañas-Linares Alicia, Antonio-Díaz Ariel, García-Sánchez Jessica, et al.
Current Neuropharmacology|April 29, 2026
Exploring Risk Drugs and Mechanisms in Dystonia: Insights from Pharmacovigilance and ProteogenomicsZhiqing Chen, Jingyi Yao, Jingqi Lin, et al.
Current Neuropharmacology|June 5, 2025
Can Sodium Oxybate Mitigate the Symptoms of Schizophrenia?Mortimer Mamelak
Current Neuropharmacology|June 3, 2025
Vortioxetine for the Treatment of Depression in Patients with Parkinson's Disease: A 16-week Pilot, Prospective, Open-label Safety StudyFabrizio Stocchi, Daniele Bravi, Fabiana Giada Radicati, et al.
Current Neuropharmacology|May 30, 2025
Early-Life Microbiome and Neurodevelopmental Disorders: A Systematic Review and Meta-AnalysisMd Fakruddin, Tasbir Amin, Md Asaduzzaman Shishir, et al.
Current Neuropharmacology|April 13, 2026
Molecular Mechanisms of Dopaminergic Neuron Degeneration in Parkinson's disease: A Comprehensive ReviewM D Abubakar, Shahnaz Alom, Farak Ali, et al.
Pageof 191